People on MSN

Toddler Diagnosed with Rare Disease at 2. After Years of Life-Changing Therapy, His Progress Could Be Stripped Away (Exclusive)

Now 4, Cade Jobsis has been receiving treatment that helps keep him strong. But with funding pulled, his parents don't know ...
The BMJ

Lecanamab: Controversial Alzheimer’s drug approved by Australian drugs regulator after two rejections

Controversial1 Alzheimer’s drug lecanemab has overcome another regulatory hurdle, with Australia’s drugs regulator approving the therapy after two rejections.2 The drug, made by Eisai, faces an uphill ...